Maximus Gage
Insulin resistance is a key characteristic of type 2 diabetes and is caused by a reduced response of target tissues to insulin, such as the skeletal muscle, liver, and adipocytes. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes, with skeletal muscle playing a central role in whole-body insulin resistance. Insulin resistance in skeletal muscle is associated with decreased insulin-stimulated glucose uptake, resulting from impaired insulin signalling and various post-receptor intracellular defects. This can lead to metabolic disorders that impair glucose homeostasis and cause persistently elevated blood glucose levels, increasing the risk of heart disease, stroke, and neuropathy.
| Characteristics | Values |
|---|---|
| Definition | Reduced response of target tissues, such as skeletal muscle, to insulin |
| Primary Defect | Skeletal muscle insulin resistance is the primary defect in Type 2 Diabetes |
| Insulin Resistance | Caused by desensitization of muscle to insulin, leading to elevated blood glucose levels |
| Onset | Can appear decades before β-cell failure and symptomatic Type 2 Diabetes |
| Risk Factors | Obesity, abdominal obesity, atherogenic dyslipidemia, hypertension, hyperuricemia, a prothrombotic state, and a proinflammatory state |
| Treatment | Strength and endurance training can increase insulin sensitivity and prevent diabetes |
| Mechanism of Treatment | Exercise stimulates glucose transport and protects against mitochondrial dysfunction |
| Prevention | Maintaining adequate muscle glucose disposal may help prevent diabetes |
Explore related products
$8.62 $15.99
$9.6 $20
What You'll Learn
Insulin resistance and type 2 diabetes
Insulin is a key hormone that regulates blood sugar levels. When you eat, food is broken down into sugars that circulate in your blood. This increase in blood sugar causes the pancreas to release insulin, which acts as a key to let blood sugar into your body cells, which use the sugar as energy. After this happens, your blood sugar returns to a normal level.
Insulin resistance occurs when the body is exposed to too much blood sugar over an extended period of time. This causes the pancreas to pump out high levels of insulin to get more blood sugar into the cells. Over time, the cells stop responding well to insulin, which is known as insulin resistance. The pancreas then has to release even more insulin, and eventually, it can't keep up, leading to elevated blood sugar levels. This is a precursor to prediabetes and type 2 diabetes.
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease. Skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before overt hyperglycemia develops. Insulin resistance in skeletal muscle, due to decreased muscle glycogen synthesis, can promote atherogenic dyslipidemia by changing the pattern of ingested carbohydrates, resulting in an increase in plasma triglyceride concentrations and a reduction in plasma high-density lipoprotein concentrations.
There are ways to make the body's cells more receptive to insulin, which can help prevent or delay type 2 diabetes. Physical activity is one of the best ways to combat insulin resistance as it makes the body more sensitive to insulin and builds muscle that can absorb blood glucose. Weight loss and eating a balanced diet with non-starchy vegetables, fruits, whole grains, and lean proteins also help to relieve insulin resistance.
Kegel Muscles: Where Are These Pelvic Floor Muscles Located?
You may want to see also
Explore related products
$10.32 $15.99
$17.99 $27.99
Insulin resistance and obesity
Insulin resistance is a reduced response of target tissues, such as skeletal muscle, liver, and adipocytes, to insulin. Insulin resistance is linked to obesity, which is a pathophysiologic factor of type 2 diabetes mellitus (T2DM). Obesity is a triggering factor for diabetes associated with insulin resistance. Adipose tissue releases higher amounts of non-esterified fatty acids, glycerol, hormones, and pro-inflammatory cytokines that could participate in the development of insulin resistance.
Obesity-linked insulin resistance is mainly due to fatty acid overload in non-adipose tissues, particularly skeletal muscle and liver, where it results in high production of reactive oxygen species and mitochondrial dysfunction. Skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before β-cell failure and overt hyperglycemia develops. Studies have shown that insulin-stimulated leg muscle glucose uptake is reduced by ~50% in type 2 diabetes.
One mechanism for the signaling defects in obesity may be the increased expression and activity of several protein tyrosine phosphatases (PTPs), which dephosphorylate and thus terminate signaling propagated through tyrosyl phosphorylation events. PTP1B and LAR have been shown to dephosphorylate the insulin receptor and IRS-1 in vitro. In addition, insulin resistance and hyperinsulinemia can contribute to the development of obesity.
The association of obesity with type 2 diabetes has been recognized for decades, and the major basis for this link is the ability of obesity to engender insulin resistance. Insulin resistance can happen due to a combination of genetics and lifestyle and is related to inflammation in the body. The American Heart Association reports that 70% of people with obesity have insulin resistance. Treating it early can help a person avoid type 2 diabetes and other related health issues.
Pushups: Targeting Your Chest and Triceps
You may want to see also
Explore related products
Insulin resistance and mitochondrial dysfunction
Insulin resistance is a characteristic feature of type 2 diabetes and is present in most prediabetic individuals. It is defined as a reduced response of target tissues, such as skeletal muscle, liver, and adipocytes, to insulin. Skeletal muscle plays a central role in whole-body insulin resistance, and insulin resistance in skeletal muscle can promote atherogenic dyslipidemia. Obesity-linked insulin resistance is mainly due to fatty acid overload in non-adipose tissues, particularly skeletal muscle and liver, resulting in high production of reactive oxygen species and mitochondrial dysfunction.
Mitochondrial dysfunction is associated with type 2 diabetes and age-related insulin resistance. It is caused by excessive energy intake, genetic factors, oxidative stress, mitochondrial biogenesis, and aging, which affect mitochondrial function, leading to insulin resistance. Mitochondrial dysfunction leads to decreased beta-oxidation and ATP production and increased ROS production, resulting in insulin resistance, diabetes, and cardiovascular disease. Interventions that improve mitochondrial function also improve insulin resistance.
The oxidative capacity of mitochondria is determined by the expression level of OXPHOS subunits and the number and size of mitochondria. Mitochondrial dysfunction and gene expression of mitochondrial OXPHOS genes are related to insulin resistance. Mutations in mitochondrial genes caused by aging or cellular stress conditions may be one of the mechanisms underlying insulin resistance.
Exercise acts through two mechanisms to improve insulin resistance: it stimulates glucose transport by activating an insulin-independent pathway, and it protects against mitochondrial dysfunction-induced insulin resistance by increasing muscle antioxidant defenses and mitochondrial biogenesis. Antioxidant supplementation combined with endurance training increases glucose transport in insulin-resistant skeletal muscle when antioxidants increase the expression of antioxidant enzymes and/or the activity of components of the insulin signaling pathway.
In summary, insulin resistance in skeletal muscle is associated with mitochondrial dysfunction, which can lead to type 2 diabetes and cardiovascular disease. Exercise and antioxidant supplementation can improve insulin resistance by targeting mitochondrial dysfunction. Interventions that improve mitochondrial function may also help to improve insulin resistance.
Quick Muscle Recovery: Techniques for Fast Results
You may want to see also
Explore related products
Insulin resistance and metabolic syndrome
Insulin resistance occurs when cells in the muscles, fat, and liver do not respond appropriately to insulin. Insulin is a hormone produced by the pancreas that is essential for regulating blood glucose levels. Insulin resistance can lead to prediabetes or Type 2 diabetes if the body cannot produce enough insulin to manage blood sugar levels effectively, resulting in hyperglycemia.
Metabolic syndrome is a group of conditions that increase the risk of cardiovascular disease, Type 2 diabetes, and stroke. It is characterised by a combination of risk factors, including insulin resistance, abdominal obesity, high blood pressure, high triglyceride levels, and low HDL cholesterol. These factors are interconnected, with obesity and physical inactivity contributing to insulin resistance and metabolic syndrome.
Insulin resistance is a key factor in metabolic syndrome, and the two conditions are closely linked. Most people with metabolic syndrome have insulin resistance, and obesity, which is common in metabolic syndrome, can make it more difficult for cells to respond to insulin. While there is no direct link between the two conditions, healthcare providers believe that insulin resistance may be a cause of metabolic syndrome.
The exact biological mechanisms underlying the relationship between insulin resistance and metabolic syndrome are not fully understood and appear to be complex. However, studies have shown that insulin resistance in skeletal muscle can promote atherogenic dyslipidemia by altering the pattern of ingested carbohydrates, resulting in increased plasma triglyceride concentrations and reduced plasma high-density lipoprotein concentrations. Additionally, insulin resistance in skeletal muscle has been associated with defects in insulin-stimulated muscle glycogen synthesis and glucose transport/phosphorylation activity.
Exercise, particularly resistance and endurance training, can help counteract the harmful effects of obesity and improve insulin sensitivity. Exercise stimulates glucose transport through an insulin-independent pathway and protects against mitochondrial dysfunction, thereby preventing diabetes and improving obesity-linked skeletal muscle insulin resistance.
The Mystery of Under-Eye Muscle Sagging, Revealed!
You may want to see also
Explore related products
$4.99
Insulin resistance and cardiovascular disease risk
Insulin resistance is a characteristic feature of type 2 diabetes and is considered the primary defect that leads to the disease. It is defined as a reduced response of target tissues, such as skeletal muscle, liver, and adipocytes, to insulin. Skeletal muscle, in particular, plays a central role in whole-body insulin resistance as it is the predominant site of insulin-mediated glucose uptake.
Insulin resistance has been linked to an increased risk of cardiovascular disease (CVD). A large Chinese nationwide study found that glucose intolerance status exacerbated the association between insulin resistance and CVD, with prediabetic obese adults with insulin resistance at a higher risk for CVD. Furthermore, in diabetic patients, insulin resistance further increased the risk for CVD. Insulin resistance has also been associated with endothelial signaling disturbances, which can increase cardiovascular risk by disrupting the balance between endothelial vasodilator and vasoconstrictor mechanisms.
The metabolic syndrome, characterized by a clustering of risk factors for CVD, includes insulin resistance, abdominal obesity, atherogenic dyslipidemia, hypertension, and a proinflammatory state. Insulin resistance in skeletal muscle can promote atherogenic dyslipidemia by changing the pattern of ingested carbohydrates, resulting in increased plasma triglyceride concentrations and reduced plasma high-density lipoprotein concentrations. This, in turn, can lead to an increased risk of CVD.
Obesity-linked insulin resistance is primarily due to fatty acid overload in non-adipose tissues, particularly skeletal muscle and liver, resulting in high production of reactive oxygen species and mitochondrial dysfunction. However, studies have shown that resistance and endurance training can help counteract the harmful effects of obesity by increasing insulin sensitivity and preventing diabetes. Additionally, antioxidant supplementation combined with endurance training can further increase glucose transport in insulin-resistant skeletal muscle when specific antioxidants are used.
Muscular Attraction: What Physique Draws Women In?
You may want to see also
Frequently asked questions
Insulin resistance is a defect in insulin-stimulated muscle glycogen synthesis caused by defects in insulin-stimulated glucose transport/phosphorylation activity.
The exact mechanism that leads to the development of muscle insulin resistance is not yet fully understood. However, an increased intramyocellar fat content and fatty acid metabolites have been shown to play a pivotal role.
Muscle insulin resistance disrupts both the amount of glucose uptake into skeletal muscle and the timing of that uptake.
Muscle insulin resistance can be treated through strength and endurance training, which can increase insulin sensitivity and prevent diabetes.
Muscle insulin resistance is a core defect in Type 2 Diabetes, which is characterised by impaired glucose homeostasis and persistent elevation of blood glucose levels.
